speb/financial-data huggingface dataset:
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 2290000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 2290000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -6640000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -6640000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -6640000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -6640000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 4217320000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 4217320000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Write Off: 120000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 195380000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2214310000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 39136476.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 4.03
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1799360000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 39136476.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 4.03
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 157720000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 219560000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 219560000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 414950000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 1110000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1110000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -5870000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 157720000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 157720000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 163580000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 157720000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 157720000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 163590000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -1110000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1110000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 219560000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 157720000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 219570000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2214310000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 152090000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 218450000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1799360000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 54870000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1994740000.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
JGCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 210460000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 2202770000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 132700000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1380940000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 174210000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 39217984.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 3.67
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 391860000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 88660000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1643040000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 391860000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4932340000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 16040000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1825790000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 4460310000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 51080000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 51080000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 263800000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 6870000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 39217984.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.67
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 143930000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — EBIT: 205510000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 205510000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 950000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 658820000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 376980000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 1990000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1990000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1074960000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 4983420000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 174210000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 0.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 0.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 5240000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 110880000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -6390000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income: 143930000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 143930000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 150320000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 143930000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 143930000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 150320000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -1990000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1990000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 658820000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4931390000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 13820000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 205510000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 143930000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Income: 166520000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 2202770000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 39186063.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 361370000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 9210000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 4540480000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 31790000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 27690000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 163900000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 642780000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1554380000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 154900000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 203520000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1825790000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 39186063.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4932340000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4931390000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 53200000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 5326080000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4932340000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 51080000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5043220000.00
JGCHEM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 2036250000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 282860000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 865770000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 19060000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 22200000.00
JGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 4196510000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 244320000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2484710000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 38891111.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 4.50
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2025870000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 38891111.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 4.50
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 175010000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — EBIT: 246180000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 246180000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 458840000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1100000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1100000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -8570000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income: 175010000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 175010000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 183580000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 175010000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 175010000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 183590000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1100000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1100000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 246180000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 175010000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: 214520000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2484710000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 26290000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 179350000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 245080000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2025870000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 61500000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2270190000.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
JGCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
JGCHEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 902570000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 252420000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 9729300000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2861690000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 109180000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 109180000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1710280000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1710280000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 146280000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 146280000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 39505423.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 4.61
JGCHEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 313770000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -390260000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 391860000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 391860000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 162170000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 162170000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1734390000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1734390000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -39190000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 181410000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -87730000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: -51190000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -279660000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -237170000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -151590000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 391860000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 391860000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 5284180000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5284180000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 77600000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 77600000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 8058600000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2407560000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 4789330000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 4789330000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 64480000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 64480000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 64480000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 64480000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 256910000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 256910000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 20120000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 20120000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 52030000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 52030000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 39505423.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 4.61
JGCHEM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 658780000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 182120000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 60000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — EBIT: 926530000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — EBIT: 255280000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — EBITDA: 978560000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 255280000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -10000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 162170000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 9250000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 45480000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -45650000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -230000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 640000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 640000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 749830000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 749830000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Gross Profit: 1670700000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 454130000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense: 5390000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1190000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 5390000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1190000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -5450000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 58980000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Inventory: 918020000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 918020000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 5348660000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5348660000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -596580000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 146280000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 146280000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 0.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 0.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -490000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 5210000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 5210000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 126360000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 126360000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Minority Interests: -27710000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -6880000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -10940000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Net Income: 658780000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income: 182120000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 658780000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 182120000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 686480000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 189010000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 658780000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 182120000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 658780000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 182120000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 921140000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 686490000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 189000000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -5390000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1190000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -266050000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 62490000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -490000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -5390000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1190000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 10000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 10000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 749830000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 749830000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -389580000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 62980000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 5283540000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5283540000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 19840000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 19840000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 978560000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 255280000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Normalized Income: 658780000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 182120000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 435740000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Operating Income: 768130000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 201710000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 9729300000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2861690000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 39186063.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 39186063.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 423220000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 423220000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 26580000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 26580000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 4892320000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 4892320000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 640000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 640000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -36080000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 6420000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 6420000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 158410000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 53570000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 690910000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 195570000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 672230000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 672230000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 1572220000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1572220000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Payables: 109180000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 109180000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 22330000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Pretax Income: 921140000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 254090000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 80000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1802440000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -390260000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 8058600000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2407560000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 52030000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -490000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 1536390000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 680000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 39186063.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 39186063.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 5284180000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5284180000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 5283540000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5283540000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Tax Provision: 234660000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 65080000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 3420000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 3420000.00
JGCHEM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -228790000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 5692500000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 5692500000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 5284180000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5284180000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 64480000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 64480000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 5410540000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5410540000.00
JGCHEM.NS income_statement (annual, 2026-03-31) — Total Expenses: 8961170000.00
JGCHEM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 2659980000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 281960000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 281960000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 903170000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 903170000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 25050000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 25050000.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 0.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 0.00
JGCHEM.NS balance_sheet (annual, 2026-03-31) — Working Capital: 4532420000.00
JGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 4532420000.00
JGGI.L income_statement (annual, 2021-06-30) — +Operating Expense: 631000.00
JGGI.L income_statement (annual, 2021-06-30) — +Total Revenue: 157149000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Accounts Payable: 11041000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Additional Paid In Capital: 119420000.00
JGGI.L cash_flow (annual, 2021-06-30) — Beginning Cash Position: 36972000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Capital Stock: 7746000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 55933000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Federal Funds Sold: 55933000.00
JGGI.L cash_flow (annual, 2021-06-30) — Cash Dividends Paid: -18884000.00
JGGI.L cash_flow (annual, 2021-06-30) — Change In Accrued Expense: 0.00
JGGI.L cash_flow (annual, 2021-06-30) — Change In Other Current Liabilities: 0.00
JGGI.L cash_flow (annual, 2021-06-30) — Change In Payable: 0.00
JGGI.L cash_flow (annual, 2021-06-30) — Change In Receivables: -453000.00
JGGI.L cash_flow (annual, 2021-06-30) — Change In Working Capital: -453000.00
JGGI.L cash_flow (annual, 2021-06-30) — Changes In Cash: 18942000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Common Stock: 7746000.00
JGGI.L cash_flow (annual, 2021-06-30) — Common Stock Dividend Paid: -18884000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Common Stock Equity: 653374000.00
JGGI.L cash_flow (annual, 2021-06-30) — Common Stock Issuance: 38179000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Derivative Product Liabilities: 1271000.00
JGGI.L income_statement (annual, 2021-06-30) — Diluted NI Availto Com Stockholders: 155242000.00
JGGI.L cash_flow (annual, 2021-06-30) — Dividend Received Cfo: 8535000.00
JGGI.L cash_flow (annual, 2021-06-30) — Effect Of Exchange Rate Changes: 19000.00
JGGI.L cash_flow (annual, 2021-06-30) — End Cash Position: 55933000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 654694000.00
JGGI.L cash_flow (annual, 2021-06-30) — Financing Cash Flow: 39189000.00
JGGI.L cash_flow (annual, 2021-06-30) — Free Cash Flow: 4613000.00
JGGI.L cash_flow (annual, 2021-06-30) — Gain Loss On Investment Securities: -8535000.00
JGGI.L income_statement (annual, 2021-06-30) — Gain On Sale Of Security: 87185000.00
JGGI.L income_statement (annual, 2021-06-30) — General And Administrative Expense: 612000.00
JGGI.L income_statement (annual, 2021-06-30) — Interest Expense: 1038000.00
JGGI.L income_statement (annual, 2021-06-30) — Interest Income: 21000.00
JGGI.L cash_flow (annual, 2021-06-30) — Interest Paid Cfo: -893000.00
JGGI.L cash_flow (annual, 2021-06-30) — Interest Received Cfo: 21000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Invested Capital: 703306000.00
JGGI.L cash_flow (annual, 2021-06-30) — Investing Cash Flow: -24860000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Investmentin Financial Assets: 657261000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Investments And Advances: 657261000.00
JGGI.L cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 38179000.00
JGGI.L cash_flow (annual, 2021-06-30) — Issuance Of Debt: 19894000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 49932000.00
JGGI.L cash_flow (annual, 2021-06-30) — Long Term Debt Issuance: 19894000.00
JGGI.L cash_flow (annual, 2021-06-30) — Long Term Debt Payments: 0.00
JGGI.L cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 38179000.00
JGGI.L cash_flow (annual, 2021-06-30) — Net Foreign Currency Exchange Gain Loss: 26000.00
JGGI.L income_statement (annual, 2021-06-30) — Net Income: 155242000.00
JGGI.L income_statement (annual, 2021-06-30) — Net Income Common Stockholders: 155242000.00
JGGI.L income_statement (annual, 2021-06-30) — Net Income Continuous Operations: 155242000.00
JGGI.L income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: 155242000.00
JGGI.L income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: 155242000.00
JGGI.L cash_flow (annual, 2021-06-30) — Net Income From Continuing Operations: 9493000.00
JGGI.L income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: 155242000.00
JGGI.L income_statement (annual, 2021-06-30) — Net Interest Income: -1017000.00
JGGI.L cash_flow (annual, 2021-06-30) — Net Investment Purchase And Sale: -24860000.00
JGGI.L cash_flow (annual, 2021-06-30) — Net Issuance Payments Of Debt: 19894000.00
JGGI.L cash_flow (annual, 2021-06-30) — Net Long Term Debt Issuance: 19894000.00
JGGI.L cash_flow (annual, 2021-06-30) — Net Other Financing Charges: 0.00
JGGI.L balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 653374000.00
JGGI.L income_statement (annual, 2021-06-30) — Normalized Income: 155242000.00
JGGI.L cash_flow (annual, 2021-06-30) — Operating Cash Flow: 4613000.00
JGGI.L income_statement (annual, 2021-06-30) — Operating Revenue: 157149000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 151129285.00
JGGI.L cash_flow (annual, 2021-06-30) — Other Non Cash Items: -21000.00
JGGI.L income_statement (annual, 2021-06-30) — Other Operating Expenses: 19000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Other Payable: 4729000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Payables: 15770000.00
JGGI.L income_statement (annual, 2021-06-30) — Pretax Income: 156518000.00
JGGI.L cash_flow (annual, 2021-06-30) — Purchase Of Investment: -460877000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Receivables: 7153000.00
JGGI.L cash_flow (annual, 2021-06-30) — Repayment Of Debt: 0.00
JGGI.L cash_flow (annual, 2021-06-30) — Sale Of Investment: 436017000.00
JGGI.L income_statement (annual, 2021-06-30) — Selling And Marketing Expense: 0.00
JGGI.L income_statement (annual, 2021-06-30) — Selling General And Administration: 612000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Share Issued: 154905500.00
JGGI.L balance_sheet (annual, 2021-06-30) — Stockholders Equity: 653374000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Tangible Book Value: 653374000.00
JGGI.L income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
JGGI.L income_statement (annual, 2021-06-30) — Tax Provision: 1276000.00
JGGI.L income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.01
JGGI.L cash_flow (annual, 2021-06-30) — Taxes Refund Paid: -1496000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Total Assets: 720347000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Total Capitalization: 703306000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Total Debt: 49932000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 653374000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 66973000.00
JGGI.L balance_sheet (annual, 2021-06-30) — Treasury Shares Number: 3776215.00
JGGI.L income_statement (annual, 2022-06-30) — +Operating Expense: 613000.00
JGGI.L income_statement (annual, 2022-06-30) — +Total Revenue: -23542000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Accounts Payable: 2417000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 178622000.00
JGGI.L income_statement (annual, 2022-06-30) — Basic Average Shares: 158538647.00
JGGI.L income_statement (annual, 2022-06-30) — Basic EPS: -0.16
JGGI.L cash_flow (annual, 2022-06-30) — Beginning Cash Position: 55933000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Capital Stock: 8305000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 41963000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Federal Funds Sold: 41963000.00
JGGI.L cash_flow (annual, 2022-06-30) — Cash Dividends Paid: -24915000.00
JGGI.L cash_flow (annual, 2022-06-30) — Change In Accrued Expense: -6310000.00
JGGI.L cash_flow (annual, 2022-06-30) — Change In Other Current Liabilities: 0.00
JGGI.L cash_flow (annual, 2022-06-30) — Change In Payable: 0.00
JGGI.L cash_flow (annual, 2022-06-30) — Change In Receivables: -32000.00
JGGI.L cash_flow (annual, 2022-06-30) — Change In Working Capital: -6342000.00
JGGI.L cash_flow (annual, 2022-06-30) — Changes In Cash: -13973000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Common Stock: 8305000.00
JGGI.L cash_flow (annual, 2022-06-30) — Common Stock Dividend Paid: -24915000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Common Stock Equity: 669413000.00
JGGI.L cash_flow (annual, 2022-06-30) — Common Stock Issuance: 66889000.00
JGGI.L cash_flow (annual, 2022-06-30) — Common Stock Payments: 0.00
JGGI.L balance_sheet (annual, 2022-06-30) — Derivative Product Liabilities: 5072000.00
JGGI.L income_statement (annual, 2022-06-30) — Diluted Average Shares: 158538647.00
JGGI.L income_statement (annual, 2022-06-30) — Diluted EPS: -0.16
JGGI.L income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: -25563000.00
JGGI.L cash_flow (annual, 2022-06-30) — Dividend Received Cfo: 12531000.00
JGGI.L cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: 3000.00
JGGI.L cash_flow (annual, 2022-06-30) — End Cash Position: 41963000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 676778000.00
JGGI.L cash_flow (annual, 2022-06-30) — Financing Cash Flow: 39928000.00
JGGI.L cash_flow (annual, 2022-06-30) — Free Cash Flow: 2770000.00
JGGI.L cash_flow (annual, 2022-06-30) — Gain Loss On Investment Securities: 22293000.00
JGGI.L income_statement (annual, 2022-06-30) — Gain On Sale Of Security: 87857000.00
JGGI.L income_statement (annual, 2022-06-30) — General And Administrative Expense: 577000.00
JGGI.L income_statement (annual, 2022-06-30) — Interest Expense: 1496000.00
JGGI.L income_statement (annual, 2022-06-30) — Interest Income: 147000.00
JGGI.L cash_flow (annual, 2022-06-30) — Interest Paid Cff: -1475000.00
JGGI.L cash_flow (annual, 2022-06-30) — Interest Paid Cfo: -1475000.00
JGGI.L cash_flow (annual, 2022-06-30) — Interest Received Cfo: 147000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Invested Capital: 719159000.00
JGGI.L cash_flow (annual, 2022-06-30) — Investing Cash Flow: -56671000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Investmentin Financial Assets: 681415000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Investments And Advances: 681415000.00
JGGI.L cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 66889000.00
JGGI.L cash_flow (annual, 2022-06-30) — Issuance Of Debt: 0.00
JGGI.L balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 49746000.00
JGGI.L cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 0.00
JGGI.L cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -199000.00
JGGI.L cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 66889000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Net Debt: 7783000.00
JGGI.L cash_flow (annual, 2022-06-30) — Net Foreign Currency Exchange Gain Loss: -3112000.00
JGGI.L income_statement (annual, 2022-06-30) — Net Income: -25563000.00
JGGI.L income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -25563000.00
JGGI.L income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -25563000.00
JGGI.L income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -25563000.00
JGGI.L income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -25563000.00
JGGI.L cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: -22659000.00
JGGI.L income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -25563000.00
JGGI.L income_statement (annual, 2022-06-30) — Net Interest Income: -1349000.00
JGGI.L cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: -56671000.00
JGGI.L cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -199000.00
JGGI.L cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -199000.00
JGGI.L cash_flow (annual, 2022-06-30) — Net Other Financing Charges: 0.00
JGGI.L balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 669413000.00
JGGI.L income_statement (annual, 2022-06-30) — Normalized Income: -25563000.00
JGGI.L cash_flow (annual, 2022-06-30) — Operating Cash Flow: 2770000.00
JGGI.L income_statement (annual, 2022-06-30) — Operating Revenue: -23542000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 166086285.00
JGGI.L cash_flow (annual, 2022-06-30) — Other Non Cash Items: -125000.00
JGGI.L income_statement (annual, 2022-06-30) — Other Operating Expenses: 22000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Payables: 2417000.00
JGGI.L income_statement (annual, 2022-06-30) — Pretax Income: -24155000.00
JGGI.L cash_flow (annual, 2022-06-30) — Purchase Of Investment: -554563000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Receivables: 3270000.00
JGGI.L cash_flow (annual, 2022-06-30) — Repayment Of Debt: -199000.00
JGGI.L cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: 0.00
JGGI.L cash_flow (annual, 2022-06-30) — Sale Of Investment: 497892000.00
JGGI.L income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 14000.00
JGGI.L income_statement (annual, 2022-06-30) — Selling General And Administration: 591000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Share Issued: 166086285.00
JGGI.L balance_sheet (annual, 2022-06-30) — Stockholders Equity: 669413000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Tangible Book Value: 669413000.00
JGGI.L income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
JGGI.L income_statement (annual, 2022-06-30) — Tax Provision: 1408000.00
JGGI.L income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.19
JGGI.L cash_flow (annual, 2022-06-30) — Taxes Refund Paid: 37000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Total Assets: 726648000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Total Capitalization: 719159000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Total Debt: 49746000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 669413000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 57235000.00
JGGI.L balance_sheet (annual, 2022-06-30) — Treasury Shares Number: 0.00
JGGI.L income_statement (annual, 2023-06-30) — +Operating Expense: 4081000.00
JGGI.L income_statement (annual, 2023-06-30) — +Total Revenue: 170019000.00
JGGI.L balance_sheet (annual, 2023-06-30) — Accounts Payable: 1983000.00
JGGI.L balance_sheet (annual, 2023-06-30) — Additional Paid In Capital: 1195317000.00
JGGI.L income_statement (annual, 2023-06-30) — Basic Average Shares: 323899982.00
JGGI.L income_statement (annual, 2023-06-30) — Basic EPS: 0.50
JGGI.L cash_flow (annual, 2023-06-30) — Beginning Cash Position: 41963000.00
JGGI.L balance_sheet (annual, 2023-06-30) — Capital Stock: 19752000.00
JGGI.L balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 160708000.00
JGGI.L balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Federal Funds Sold: 160708000.00
JGGI.L cash_flow (annual, 2023-06-30) — Cash Dividends Paid: -46375000.00
JGGI.L cash_flow (annual, 2023-06-30) — Change In Accrued Expense: 311000.00
JGGI.L cash_flow (annual, 2023-06-30) — Change In Other Current Liabilities: 0.00
JGGI.L cash_flow (annual, 2023-06-30) — Change In Payable: 0.00
JGGI.L cash_flow (annual, 2023-06-30) — Change In Receivables: 1000.00
JGGI.L cash_flow (annual, 2023-06-30) — Change In Working Capital: 312000.00
JGGI.L cash_flow (annual, 2023-06-30) — Changes In Cash: 118746000.00
JGGI.L balance_sheet (annual, 2023-06-30) — Common Stock: 19752000.00
JGGI.L cash_flow (annual, 2023-06-30) — Common Stock Dividend Paid: -46375000.00
JGGI.L balance_sheet (annual, 2023-06-30) — Common Stock Equity: 1812908000.00
JGGI.L cash_flow (annual, 2023-06-30) — Common Stock Issuance: 179607000.00
JGGI.L cash_flow (annual, 2023-06-30) — Common Stock Payments: -1400000.00
JGGI.L balance_sheet (annual, 2023-06-30) — Derivative Product Liabilities: 8022000.00
JGGI.L income_statement (annual, 2023-06-30) — Diluted Average Shares: 323899982.00
JGGI.L income_statement (annual, 2023-06-30) — Diluted EPS: 0.50
JGGI.L income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: 161867000.00
JGGI.L cash_flow (annual, 2023-06-30) — Dividend Received Cfo: 27498000.00
JGGI.L cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: -1000.00
JGGI.L cash_flow (annual, 2023-06-30) — End Cash Position: 160708000.00
JGGI.L balance_sheet (annual, 2023-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1793910000.00
JGGI.L cash_flow (annual, 2023-06-30) — Financing Cash Flow: 124520000.00
JGGI.L cash_flow (annual, 2023-06-30) — Free Cash Flow: 26550000.00